Streetbeat News

Stock Prices

TFC

Evercore ISI Group analyst John Pancari has maintained an In-Line rating on Truist Financial Corporation (NYSE:TFC) and increased the price target from $31 to $33.

Portfolio Pulse from Benzinga Newsdesk

November 20, 2023 | 5:07 pm

OSCR

Oscar Health's stock price has risen following the announcement that an affiliate of Deerfield Management Company and the Anahata Foundation will purchase shares from a selling shareholder under a Stock Purchase Agreement.

Portfolio Pulse from Benzinga Newsdesk

November 20, 2023 | 5:02 pm

DELL

Over the past 3 months, 15 analysts have provided ratings for Dell Technologies (NYSE:DELL), with an average 12-month price target of $74.13, ranging from $53.00 to $95.00. The majority of analysts are bullish or somewhat bullish, with 5 bullish, 8 somewhat bullish, 1 indifferent, and 1 somewhat bearish ratings. The average price target has increased by 19.12% over the past month.

Portfolio Pulse from Benzinga Insights

November 20, 2023 | 5:01 pm

CAKE

Over the past quarter, Cheesecake Factory (NASDAQ:CAKE) received 10 analyst ratings with an average 12-month price target of $31.2, a decrease from the previous target of $34.33. The ratings include 1 somewhat bullish, 6 indifferent, and 3 somewhat bearish. No fully bullish or bearish ratings were given. Analysts provide these ratings to help investors make informed decisions, though they reflect opinions and are subject to human error.

Portfolio Pulse from Benzinga Insights

November 20, 2023 | 5:00 pm

WLK

Westlake (NYSE:WLK) has received mixed analyst ratings in the last quarter, with 2 somewhat bullish, 1 indifferent, and 1 somewhat bearish. The average 12-month price target among 4 analysts is $139.5, with a high of $150.00 and a low of $129.00. This target is a 3.46% decrease from the previous target of $144.50. Analysts rate stocks based on future earnings potential and company risk, typically updating their ratings quarterly or after significant company events.

Portfolio Pulse from Benzinga Insights

November 20, 2023 | 5:00 pm

INSM

Over the past 3 months, 7 Wall Street analysts have provided ratings for Insmed (NASDAQ:INSM), with 3 being bullish and 4 somewhat bullish. The average price target is $45.57, representing an implied upside from the current price of $24.82. This target has increased by 11.83% from the previous target of $40.75. Analyst ratings are important as they can influence investor expectations and stock prices.

Portfolio Pulse from Benzinga Insights

November 20, 2023 | 5:00 pm

CHRD

Stifel has maintained its Buy rating for Chord Energy (NASDAQ:CHRD) but reduced its price target from $185.00 to $183.00. Chord Energy's shares are currently trading at $163.20, and the new price target suggests a potential upside of 12.13%. Chord Energy is an independent oil and gas company focused on exploration and production in the Williston Basin.

Portfolio Pulse from Benzinga Insights

November 20, 2023 | 5:00 pm

SWTX

HC Wainwright & Co. has maintained a Buy rating for SpringWorks Therapeutics (NASDAQ:SWTX) but lowered its price target from $58.00 to $52.00. Despite the reduction in the price target, the new target suggests a significant upside of 133.18% from the current trading price of $22.30. SpringWorks Therapeutics is a clinical-stage biopharmaceutical company focused on developing medicines for rare diseases and cancer.

Portfolio Pulse from Benzinga Insights

November 20, 2023 | 5:00 pm

SPRB

Over the past quarter, Spruce Biosciences (NASDAQ:SPRB) received 4 analyst ratings, with 2 being bullish and 2 somewhat bullish. There were no indifferent, somewhat bearish, or bearish ratings. The average 12-month price target for SPRB is $9.25, with a high of $10.00 and a low of $8.00. This target has increased by 208.33% over the past month. Analyst ratings are based on future earnings predictions and company risk assessments, and are updated quarterly or after major company events.

Portfolio Pulse from Benzinga Insights

November 20, 2023 | 5:00 pm

GGB

B of A Securities has downgraded Gerdau (NYSE:GGB) from its previous rating to Neutral, adjusting the price target from $5.60 to $5.10. Gerdau's shares have fallen 2.31% in the last 24 hours to $4.81. The new price target suggests a potential upside of 6.03% from the current price. Gerdau is a steel producer with operations primarily in Brazil, but also in North America and South America, and specializes in various steel products.

Portfolio Pulse from Benzinga Insights

November 20, 2023 | 5:00 pm